Multiple Sclerosis (MS) is almost always accompanied by fatigue, a massive tiredness that is described by the vast majority of patients as the most distressing symptom. In a recent scientific study, a research group led by Stefan Seidel from the Department of Neurology at MedUni Vienna and AKH Vienna identified light therapy as a promising non-drug treatment option: patients included in the study showed a measurable improvement after just 14 days of use. The study results were recently published in the Multiple Sclerosis Journal — Experimental, Translational and Clinical.

For the first time, Stefan Seidel’s research team relied not only on surveys but also on objective measurements when selecting the test persons. For example, sleep-wake disorders were ruled out in the 26 participating MS patients, particularly with the assistance of various sleep medicine examinations. “In this manner, for example, we ensured that MS patients with fatigue do not suffer from sleep apnea or periodic leg movements during sleep. Both are sleep disorders that can lead to fatigue in everyday life,” elaborated study leader Stefan Seidel.

Performance improvement

The test persons — all patients of the Neurology Department at MedUni Vienna and AKH Vienna — were equipped with commercially available light sources for self-testing at home: Half of the participants received a daylight lamp with a brightness of 10,000 lux, while the other half received an identical lamp that emitted a red light with an intensity of

Up to 99 percent of patients

Fatigue is a severe form of tiredness and fatigability that occurs in 75 to 99 percent of people with MS and is described as particularly distressing. Nerve damage triggered by MS is being discussed as the cause. In addition to behavioural measures, such as regular rest breaks, various medications are currently available to alleviate fatigue, but some of these are associated with severe side effects. “The findings from our study represent a promising non-drug therapeutic approach,” Stefan Seidel affirms. However, the results still need to be confirmed in a subsequent larger-scale study. The exact background of the invigorating effect of light therapy on MS patients will also be the subject of further scientific research.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Before you post, please prove you are sentient.

what is 2 in addition to 3?

Explore More

Advanced ‘Parkinson’s in a dish’ model accelerates brain disease research

Researchers at Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, have developed a model that rapidly converts stem cells to brain cells with protein

New immunosuppressive mechanism found in brain cancer

The Wistar Institute assistant professor Filippo Veglia, Ph.D., and team, have discovered a key mechanism of how glioblastoma — a serious and often fatal brain cancer — suppresses the immune

Discovery of key mechanism in Huntington’s disease could pave the way for early detection and treatment

TrkbPenk-KO mice develop hyperactivity following DA increase. Credit: Nature Metabolism (2024). DOI: 10.1038/s42255-024-01155-z Researchers from the University of Oxford have identified a key biochemical mechanism relevant to the development of